The tumor microenvironment analysis showed a predominant T-cell suppressive activation via immune checkpoints expression predominantly via PD-L1/PD-1, and cases with tumor recurrence showed higher amounts of MCs expressing B7-H4 than did cases without recurrence. The gene discussed is VTCN1; the disease is neoplasm.